Skip to main content
Signal8

DelAversano Robert J

SEC insider (Form 3/4/5 filer). CIK 0001728262. Principal Financial Officer at Grace Therapeutics, Inc. (GRCE). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 28, 2026. Located in PRINCETON, NJ.

Companies DelAversano Robert J has filed insider reports for

  • Grace Therapeutics, Inc. (GRCE): Officer, Principal Financial Officer
DelAversano Robert J profile photo

DelAversano Robert J

CIK: 0001728262

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Grace Therapeutics, Inc. logo
GRCE

Grace Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Aug 28, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    33.7K shares-
  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Apr 14, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    20.1K shares-

1-2 of 2